Literature DB >> 22843918

hGH and GHR expression in large cell neuroendocrine carcinoma of the colon and rectum.

Zoran Jukić1, Rinë Limani, Lumturije Gashi Luci, Vivian Nikić, August Mijić, Davor Tomas, Božo Krušlin.   

Abstract

Large cell neuroendocrine carcinoma (LCNEC) is an aggressive neoplasm with a low frequency of occurrence in the digestive tract. We present a series of eight patients diagnosed with LCNEC of the colon and rectum. Grossly, tumors were presented as endophytic/ulcerative, annular and polypoid masses, with a gray-white color and necrosis in most cases. Histologically, they were high-grade tumors composed of large cells of organoid, nesting, trabecular, rosette-like and palisading patterns, with a high mitotic rate. Tumors were immunoreactive for neuroendocrine markers, including chromogranin A (2/8), synaptophysin (7/8), and neuron-specific enolase (8/8). Moreover, we analyzed the expression of growth hormone (hGH) and growth hormone receptor (GHR) in colorectal LCNECs and six tumors were immunoreactive for hGH, while five tumors were immunoreactive for GHR. To our knowledge hGH and GHR expression has not been previously analyzed in colorectal LCNEC. Their overexpression suggests a role of hGH and GHR in the development of colorectal LCNEC.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22843918

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  2 in total

1.  A case of colorectal large cell neuroendocrine carcinoma accompanied by disseminated peritoneal leiomyomatosis.

Authors:  Kunihiko Suga; Hiroomi Ogawa; Makoto Sohda; Chika Katayama; Naoya Ozawa; Katsuya Osone; Takuhisa Okada; Takuya Shiraishi; Ryuji Katoh; Akihiko Sano; Makoto Sakai; Takehiko Yokobori; Ken Shirabe; Hiroshi Saeki
Journal:  Surg Case Rep       Date:  2020-12-09

2.  Large cell neuroendocrine carcinoma of the rectum presenting with extensive metastatic disease.

Authors:  Vinay Minocha; Sania Shuja; Robert Ali; Emely Eid
Journal:  Case Rep Oncol Med       Date:  2014-07-16
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.